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Abstract: This paper reports on the LGX fluorometric test for enzymatic MRSA/MSSA detection. It 
highlights the reasons rhodamines have been overlooked and also strategies to improve the synthesis of 
rhodamine-peptide conjugates. Evaluation of the LGX test for detection of MRSA/MSSA on surfaces is 
undertaken in the presence of potentially confounding E. coli and S. epidermidis for the first time. 
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Introduction 
The growth in the number of infections caused by antibiotic resistant pathogens has prompted healthcare 
agencies around the world to generate strategic plans.1 These plans incorporate the restriction of antibiotic use to 
slow the emergence of resistant pathogens, as well as the development of new antibiotics, to which resistance 
will inevitably emerge. The former part of this strategy requires rapid, affordable diagnostics to determine the 
best clinical course of action.2 
The principle drawbacks of PCR are the laboratory requirements and the expense of each test. This drawback is  
demonstrated in the UK insofar that PCR is not routinely used to detect problem pathogens such as MRSA. 
Bacterial culture is time-consuming (48-72hrs) and as reported in the NHS NOW report specifically concerning 
MRSA, it is often the case that patients are discharged before the results of the test are known.3 
PCR techniques rely upon the enzymatic amplification of a gene until sufficient quantities can be detected. 
Bacterial culture relies upon the growth rate of a bacteria, augmented by the best media. An alternative approach 
involves the targeting of enzymes expressed by bacteria, which cleave between specific amino acid sequences.4 
To observe the actions of bacterially expressed enzymes and in common with other detection methods, a 
chromogenic response is arguably the most useful. This is evidenced by the recently reported rhodamine based 
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fluorogenic probe (1). This probe, (incorporated into a test subsequently referred to as LGX) has shown good 
selectivity and sensitivity for both Methicillin Resistant Staphylococcu aureus (MRSA) and Methicillin 
Sensitive Staphylococcus aureus (MSSA).5 
 
Figure 1. Fluorogenic Probe in LGX test (1) 
Rhodamine 110 (2) represents one of the most active fluorophores known, with a high extinction coefficient and 
a fluorescence quantum yield which is near unity. Rhodamine has been used as a marker in a wide variety of 
enyzmic activity studies (serine protease6, esterase7, caspase8, DT diaphorase9). Essentially the NH2 groups of 
rhodamine 110 are conjugated to a polypeptide, which mimics the natural substrate of the enzyme in question. 
Upon cleavage of the polypeptide mimic, the rhodamine is released and in aqueous solution undergoes a 
conversion to a highly fluorescent zwitterionic form. The change in rhodamine's fluorescence quantum yield 
from its unconjugated (lactone form), to conjugated (zwitterionic form) is considerable (Rho 110 φlactone = 0.006 
φzwitterion = 0.98). This sharp increase in fluorescence is easily detectable by even handheld instruments and often 
just the naked eye.  
 
Figure 2. Rhodamine 110 (2) 
This paper considers the previous synthetic literature for rhodamine 110 derivatives and reports on new 
exploratory approaches to the tailoring of this important fluorophore. Furthermore it addresses why rhodamine 
conjugates have not been more widely applied to pathogen detection via bacterial enzymatic action.  
The most recent review of rhodamine 110 details the methodology used for the synthesis of rhodamine 
derivatives, which is essentially unchanged since the 1980’s.  
Rhodamine 110 is reacted with a protected amino acid, which is first activated with a coupling agent. Following 
deprotection and subsequent activation, further amino acids are added in a routine fashion, however the yields 
are often poor and the costs of the initial rhodamine are high (£100/g). In addition, there is no mention of 
racemisation in any of the seminal work, on which that review is based.10 
Recent work by the authors, reports the synthesis of a novel (Boc-Val-Pro-Arg)2–Rhodamine (1), however the 
authors report considerable difficulty with which Arginine could be attached to rhodamine, which is at odds 
with the comparative ease of this achievement by Mangel et al, almost 33 years ago.11 In reference to the 
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original literature dealing with biologically relevant rhodamine conjugates, we observe multiple discrepancies 
between the compounds reported and the fluorescence data before and after enzymatic cleavage. There is no 
reported yield for the cathepsin C activated rhodamine12 or caspase conjugates8, yet these are reportedly known 
in various reviews. The synthesis of the serine protease activated rhodamine by Mangel et al is also highly 
improbable in its simplicity and purification via centrifuge.11 The only characterisation undertaken is TLC and 
low resolution MS. The elemental analysis deviates from the empirical formula, but water and HCl are 
inexplicably added to bring the observed values within tolerance. The absence of HPLC/NMR facilities when 
the work was done in 1982 means that it is unlikely the compound was specifically synthesised. The primary 
literature reports the (CBz-Arg)2-Rhodamine to be a pink powder, yet the Sinclair group reported a white solid 
after HPLC purification. The biological testing of the serine protease activated rhodamine as then reported bears 
out the fact that whatever was synthesised is impure. The UV-Vis spectra indicates there is still fluorescence of 
the rhodamine conjugate at 525nm. If the fluorescence quantum yield alone is three orders of magnitude lower 
for a Bis-NH2 conjugated rhodamine than for the free fluorophore, this fluorescence should not be visible, yet it 
is shown to be fluorescent in the original paper from 1982. The conclusion has to be that a mixture of 
rhodamine, mono Arg-Rhodamine and bis Arg-Rhodamine was in fact made. Thus the contrast between 
conjugated and unconjugated rhodamine is comparatively small and significant amounts of protease are required 
to achieve this. As a consequence, any attempt to achieve a high sensitivity e.g. for the detection of pM 
concentrations of an enzyme expressed by a pathogen would be met with failure.  
As indicated in the previous section rhodamine conjugates have been somewhat overlooked as the fluorescent 
component for practical enzymatic tests and there is a need to develop synthetic methodology to tune the 
rhodamine structure efficiently.   
Previously reported synthesis has proven capricious with initial coupling reactions of amino acids with 
rhodamine being of very low yield and this makes them less amenable to scale-up. We discuss the different 
approaches and show an improvement in the overall yield of a recently reported rhodamine conjugate (Boc-Val-
Pro-Arg)2–Rhodamine (1), which has shown remarkable selectivity and sensitivity for MRSA and MSSA as 
reported by the authors.5 
2. Results 
2.1 The xanthone approach 
2.1.1 Grignard 
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The main problem with functionalising the NH2 groups on rhodamine are the intrinsic lack of nucleophilicity of 
these, due to resonance and other effects.13 To overcome this problem the approach was taken to reduce some of 
the possible conjugation through the rhodamine via removal of the top lactone aromatic. The aim was to achieve 
a better amino acid coupling yield and introduce the lactone ring at a later stage. The method followed that of A. 
Young-Hoon et al whom originally developed the procedure to produce library of rosamines for combinatorial 
synthesis. These conditions were adapted to produce the initial required nitro amino xanthone (3) for further 
modification towards a number of novel unsymmetrical rhodamines for further study.14 
 
Figure 3. Asymmetric xanthone synthesis, as per A. Young-Hoon et al. 
The initial step is an Ullmann condensation requiring high temperatures and long reaction times. Work-up in hot 
concentrated sulphuric acid induces ring closure, to produce the xanthone core. In our hands, this step resulted 
in the expected xanthone 3 in a consistent yield of 30% (Figure 4 (a)). NMR data confirmed this (See SI-1). 
Having functionalised the NH2 of xanthone 3 with an appropriately protected amino acid e.g. N-Boc-
Arginine(Cbz)2 –OH to give 4, the upper ring system could be introduced using a Grignard type approach as 
indicated in Figure 4.  
Whilst the test reaction of phenyl magnesium bromide and unfunctionalised xanthone 6 successfully produced 
tertiary alcohol 7 (Figure 4 (b)), the Grignard reaction using acetal protected benzaldehyde on nitro amino 
xanthone 3 was unsuccessful in the production of 8, further elaboration to 9 and 10 were therefore not possible 
(Figure 4(c)). Upon examination  of the crude mixture, the expected signals were observed neither by NMR nor 
by MS, instead we obtained a complex and intractable mixture of deeply purple coloured products which could 
not be successfully isolated and characterised.  
 
Figure 4. Proposed incorporation of C ring using Grignard followed by mild oxidation. 
 
The reaction was tested a number of times with varying excesses of Grignard reagent without generating the 
product of interest (See Table SI-4). This result warranted further investigation, upon which the Bartoli indole 
synthesis was implicated. This synthesis detailed the reaction of vinyl Grignard reagents with aryl nitro 
compounds, demonstrating the reactivity of the aryl nitro group towards Grignard reagents.15  It is possible that 
attack on the deactivated ketone group of the xanthone was slower than on the nitro group demonstrating the 
incompatibility of nitro arenes with Grignard reagents, aiding explanation of the observed results. 
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2.1.2 Samarium Iodide 
During the investigation into new routes towards non-commercially available Rhodamine dye analogues, the 
reducing agent samarium iodide (SmI2) was noticed. Attention was given to this due to its ability to produce γ- 
lactones via the reductive coupling of α, β- unsaturated esters with carbonyl compounds, and the broad scope 
provided by this ability. The process by which these systems were formed starts with a carbonyl such as a 
ketone or aldehyde, which is reduced to form a ketyl type radical. The unsaturated compound then acts as a 
radicalophile to form the first bond with the ketyl radical, cyclisation follows. As a variety of γ- lactones couple 
in this way, investigation into the production of these lactones from more complex substrates such as xanthone 
was carried out.16 
 
Figure 5. (a) Reported cyclisation reaction on ideal system with SmI2 (b) SmI2 facilitated lactone formation (c) 
SmI2 facilitated conjugated lactone formation 
 
The reductive cyclisation test of cyclohexanone (11) shown in Figure 5(a) was carried out successfully to 
produce 12, (See SI - 5) however, when applied to our xanthone (6) even after 20 hours at room temperature 
there had been no reaction or indication of 13. The reaction was repeated under reflux conditions and the 
number of equivalents of SmI2 increased from 2.5 to 5. This was to address the possibility of the commercially 
obtained SmI2 solution being of lower concentration than that stated, which is widely mentioned in literature 
regarding its use.13 Subsequent reactions involved freshly prepared SmI2 solution produced from Imamoto’s 
method, standardised under nitrogen against a known volumetric solution of ultra-pure iodine in THF (See 
Table SI - 6).17,18 
Following standardisation of the freshly prepared SmI2 solution, further reactions were performed: two at room 
temperature for 20 hours as before, using precisely 2.5 equivalents of SmI2: one of which with, and one without 
the s-Butanol additive. This would compare with previous attempts so as to rule out the possibility of the 
reaction being unsuccessful due to inconsistent SmI2 solution concentrations, or indeed the inclusion of the 
alcohol proton donor additive which is usually required for this type of reductive coupling.19 
 
Figure 6. Excess SmI2 reduces the xanthone in the presence of a hydrogen donor 
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In the presence of the s-Butanol, xanthene was produced in the reaction mixture (Figure 6), implying that the 
carbonyl was simply reduced down to a CH2, but also indicates that xanthone is incompatible with the reductive 
coupling and thus unable to produce rhodamine analogues 13 – 16 (Figure 5(b) & (c)), conceivably due to 
stabilisation of the ketyl radical species formed in the first step. 
 
2.1.3 Directed metalation 
As one of the better known routes to aryl containing structures, directed metalation was investigated in the 
context of rhodamine conjugate synthesis. The Wuts group explored the use of dialkyl hydrazides as directed 
lithiating agents and this showed promise.20 Their work addressed the difficulty found when hydrolysing amide-
type directed metalating agents and found that hydrazides were more favourable. Secondary butyllithium (s-
BuLi) facilitated ortho-metalation of N',N'-dimethylbenzohydrazide (17) generated lithium species 18 (Figure 
7(a)),  followed by exposure to a number of standard electrophiles resulted in the free acid ortho addition 
product following oxidation. This is consistent with previously demonstrated amide chemistry, differing only by 
the mild oxidants required such as CuCl2 or H5IO6.20 More importantly, if the electrophile had aldehyde or 
ketone functionality it was noted that lactonisation often occurred spontaneously during workup and isolation, in 
the case of addition to cyclohexanone (19), leading to spirocyclic phthalide 20. If this chemistry were 
compatible with xanthones, it could lead to a more reliable and cost effective route to rhodamine conjugates and 
potentially facilitate the generation of novel rhodamine analogues. 
This route was initially tested on the substrate demonstrated in the literature (19) in order to confirm the 
viability of this reaction (See Figure 7(b) and supplementary information for data SI – 8). After confirmation, 
the same reaction conditions were applied to the simplest unfunctionalised xanthone core structure (6) with 
success (See Figure 7(c) and supplementary information for data SI – 9).  
 
Figure 7. General scheme for direct metalation of xanthones 
 
The hydrazide (17) shown in Figure 7. underwent ortho-metalation with s-BuLi at -78oC followed by addition to 
6. Various reaction times and equivalents were assessed; each time the crude material was a complex mixture 
which defied purification after standard workup. However, acidification with concentrated HCl resulted in the 
slow formation of the spirophthalide which crystallised over night to form needle like white crystals which were 
washed with cold ether and isolated. Upon examination by 1H NMR these appeared to be the expected product, 
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the previously unreported rhodamine core structure 21. Apparently the acidification facilitated dehydrative 
cyclisation to form the upper spirophthalide ring, which allowed the compound to crystallise out of solution. 
This demonstrated the viability of the directed metalation approach for the production of further rhodamine 
analogues 22, 23 (Figure 7(c)), however the reaction proved intolerant of the amino/nitro arrangement (Figure 
7(d)). 
 
2.2 Improvement to standard peptide chemistry 
 
2.2.1 Optimising coupling agents and conditions 
 
The ability to scale-up the synthesis of rhodamine conjugates for affordable, real-world application had, at that 
point not been achieved, and we turned our attention back to the original coupling approaches to the rhodamine 
110 core structure (2).  
The problems associated with the coupling of arginine to rhodamine are a useful exemplar reaction to the 
coupling of any amino acid to rhodamine. In respect of the steric bulk, nucleophilicity and basic nature of the 
guanidinium side-chain moiety (leading to possible side-reactions) on the arginine, this combination represents 
the worst-case scenario for such a coupling.  
 
 
 
 
 
Table 1. Initial coupling of Boc-(CBz)2Arginine to Rhodamine. Yields are the purified (Boc-(CBz)2Arginine)2-
Rhodamine. 
 
A variety of different coupling agents and protecting groups were used (Table 1) and it was possible to optimise 
the conditions to obtain an initial coupling yield of 25%.This was achieved when using the powerful coupling 
agent HATU, which has been shown to be effective in difficult couplings especially with sterically hindered 
amino acids.21,22 Equally as important, the yield was consistent throughout several runs and represents a sound 
method for scaling the initial coupling. 
Coupling Reagent Isolated yield 
EEDQ - 
PPh3Cl - 
EDCI/Oxyma 5% 
COMU 8% 
HATU 25% 
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2.2.2  Scale-up problems with deprotection of Cbz groups 
The previously reported synthesis of (Boc-Val-Pro-Arg)2–Rhodamine involves the direct attachment of an 
exhaustively CBz protected Boc-arginine with a particularly poor yield (17%), with subsequent amino acids 
being added prior to deprotection via hydrogenation. However, this approach is not amenable to scale-up and 
larger amounts of (Boc-Val-Pro-Arg(CBz)2)2–Rhodamine cannot be successfully deprotected either by using 
standard or non-standard hydrogenation techniques. This is evidenced in a report by Peakdale Molecular Ltd, 
which can be found in supporting information (SI - 10 and SI - 11). Indeed, the rate of hydrogenation of the 
central benzyl ester was shown to be greater for (Boc-Val-Pro-Arg(CBz)2)2–Rhodamine (1) than rate of loss of 
the Cbz groups (Figure 8). 
 
 
Figure 8. Diagram showing the hydrogenolysis of the lactone of (Boc-Val-Pro-Arg(CBz)2)2–Rhodamine (24) 
and Lactone formation using DDQ and the reduced (Boc-Val-Pro-Arg)2–Rhodamine derivative (25). 
For the real world application of (Boc-Val-Pro-Arg)2–Rhodamine (1) to the in situ detection of S. aureus in both 
clinical and non clinical environments, the final CBz deprotection step and its selectivity is critical and  equally 
applicable to the development of other protease probes containing the CBz protecting group. This is because the 
hydrogenated lactone (25) is not fluorescent and so its liberation upon cleavage of the peptide side chain 
produces no fluorescence contrast change, rendering the probe ineffective. 
 
Since all hydrogenation steps failed to selectively remove the CBz groups and  leave the central lactone intact 
when scaled up, an alternative approach was adopted. If we cannot avoid the loss of the lactone, would it be 
possible to reform the required functionality after exhaustive hydrogenation (removing the Cbz groups and 
opening up the lactone to give 25) through subsequent oxidation? The oxidant 2,3-Dichloro-5,6-dicyano-1,4-
benzoquinone (DDQ) was selected for its oxidative coupling ability and a test reaction was set up to be 
monitored by proton NMR. Dissolution of the inactivated product in MeOD with an excess of  DDQ allowed 
reaction progress to be monitored by proton NMR at 1 minute intervals.23 We were delighted to observe the 
reappearance of the lactone functionality through disappearance of the signal for the benzylic proton in question. 
This method was then applied to a scaled up completion of the synthesis, using 8 equivalents of DDQ in MeOH, 
it was possible to reform the central lactone of the rhodamine core (Figure 8) to yield 1. 
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The yield of this reaction is high (83%) and the correct structure was verified with NMR and HR MS (See SI -
12 & SI - 13).  Details of the synthetic chemistry, including general experimental spectroscopic data are 
available in supplementary information. 
 
 
2.3 Biological Testing For Surface Detection 
2.3.1 Preparation of bacterial samples 
Clinical isolates of  MRSA, MSSA,  S. epidermidis and E. coli, were revived from - 80°C and cultured 
overnight on Brain Heart Infusion (BHI) agar at 37°C, followed by two subcultures on nutrient agar.  For each 
experiment, an inoculum of a respective bacterial species was cultured overnight in 100 mL nutrient broth under 
shaking conditions, and each bacterial sample was then washed with 1 x phosphate buffered saline (PBS) by 
centrifugation at 4000 rpm, and bacterial concentrations of 104, 103 and 102 colony forming units per ml (CFU 
mL-1), were created by serial dilution of the bacteria in 1x PBS. 
 
Co-cultures of varying ratios of MRSA/MSSA with S. epidermidis and E. coli were produced using the relative 
cell count percentages as detailed in the table below (Table 2). 
 
Co-culture MRSA or MSSA S. epidermidis E.coli 
A 20 % 10% 70% 
B 20 % 20% 60% 
C 20 % 30% 50% 
D 20 % 40% 40% 
E 20 % 50% 30% 
F 20 % 60% 20% 
G 20 % 70% 10% 
Table 2. Bacterial co-culture ratios designated A-G 
Stainless steel coupons were washed, rinsed and placed in a glass petri dish followed by sterilisation using an 
autoclave. These were placed in an incubator overnight to ensure thorough drying of each plate. A bacterial 
inoculum of a single strain of MRSA or MSSA, in addition to S. epidermidis and E. coli, was cultured overnight 
in 100 mL nutrient broth. A 4 mL aliquot of each bacterial suspension was then cultured in 100 mL nutrient 
broth aerobically for 4 hours under shaking conditions. Each bacterial sample was harvested by centrifugation at 
4000 rpm and washed with 1 x Phosphate buffered saline (PBS), and bacterial concentrations of 104, 103 and 102 
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CFU mL-1 were generated by serial dilution of bacteria in 1x PBS supplemented with 10 % heat inactivated fetal 
bovine serum (FBS).  
A 50 µL aliquot of each bacterial sample was pipetted aseptically onto the steel coupons, and these were 
incubated aerobically overnight at 37°C. A cotton wool swab soaked in PBS was then used to remove the 
bacteria, and this was placed in an Eppendorf tube with 100 µL of sterile PBS, the tube was then vortexed to 
dislodge bacteria from the swab.  
This was performed twice: once with using the LGX test (using a 100 µM LGX solution), and once using 
bacterial culture to determine cell viability. Swabbing was performed as described above in the experimental 
section. This process was repeated 3 times and the results shown in Figure 9 and 10 are averages with standard 
deviation error bars. 
 
2.3.2 Preparation of LGX  
A 100 µM and 50 µM solution of LGX was prepared by dissolving fluorophore 1 in 2.5 % methanol followed  
by dilution in 1 x PBS. Solutions of Tris Base (0.05 M) and NaCl (0.1 M) in deionised H2O were added to the 
solution until an optimum pH of 8.5 was achieved. The appropriate amount of human prothrombin in 1 x PBS 
was then added to produce final prothrombin concentrations of 83.6 nM and 41.8 nM, respectively. The 
resulting solution was termed “LGX“. The concentrations of LGX, subsequently discussed, refer to the 
concentration of the active fluorophore 1. The presence of coagulase positive bacteria was determined by 
addition of 100 µM LGX solution followed by5µL prothrombin. The fluorescence was then recorded (excitation 
488 nm and emission 525 nm) at 15 minute intervals over a 2.5 hour time period using a benchtop fluorimeter 
(BMG FLUOstar OPTIMA). 
 
3. Discussion 
 
As can be observed, the majority of samples test positive for MRSA (denoted by a fluorescence reading 
exceeding 20,000 RFU). Figure 7 demonstrates the effects of co-culturing E. coli and S. epidermidis on the 
efficacy of detecting MRSA using the LGX system.  The graph depicts the mean fluorescence response of 2 
strains of MRSA tested on separate occasions.  
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Figure 9. Fluorescence response of LGX for the different co-cultures of MRSA (20% of 103 CFU/ml) over 2.5 
hours. Results also include LGX (100uM), Negative Control (E. coli 103 CFU/ml) and Postive Control (MRSA 
103 CFU/ml). 
 
 
 
 
Figure 10. Fluorescence response for LGX for the different co-cultures of MSSA (20% of 103 CFU/ml) over 2.5 
hours. Results also include LGX (100uM), Negative Control (E. coli 103 CFU/ml) and Postive Control 
(MSSA103 CFU/ml)  
 
Over the 2.5 hour test period, fluorescence intensity increases gradually for all samples with the positive control 
(containing the coagulase positive MRSA strain alone) showing a much increased response. The varying ratios 
of S. epidermidis and E. coli however do not bear any conclusive effect on the efficacy of LGX as the 
fluorescence intensity is not affected by more S. epidermidis and less E. coli or vice versa. Also, the absence of 
S. epidermidis and E. coli also does not affect the potential of LGX to detect very small amounts of MRSA (at 
20% of the original bacterial concentration), and so, this data suggests that the presence of other bacteria does 
not hamper the efficacy of LGX to detect MRSA.  
 
However, it is noted that the presence of FBS in the experimental system may interfere with the fluorescence 
potential of LGX, and this requires further investigation. 
 
Figure 8 demonstrates the effects of co culturing E. coli and S. epidermidis and MSSA (a coagulase positive 
organism) on the efficacy of detecting MSSA using the LGX system (ratios of MSSA/MRSA with 
contaminating organisms can be found in Table 2).  As with MRSA  (Figure 8), the data shows the average of 2 
strains of MSSA tested on separate occasions. Over the 2.5 hour test period, fluorescence intensity remained 
constant, and the varying ratios of S. epidermidis and E. coli do not tend to bear a conclusive effect of the 
efficacy of LGX as the fluorescence intensity is not affected by more S. epidermidis and less E. coli or vice 
versa. Also, the absence of S. epidermidis and E. coli did tend to increase the potential of LGX to detect very 
small amounts of MRSA (at 20% of the original bacterial concentration) (Figure 7). This observation is not so 
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clear when considering MSSA (Figure 8). This result is interesting in the respect that previous experiments have 
shown that LGX is more sensitive at detecting MSSA when compared to testing for MSSA (fluorescence 
intensity peaks at lower time points). This may be indicative that this system, in a more “real life” scenario, may 
be more sensitive and selective in terms of MRSA detection over MSSA or that the expression of coagulase 
might be heightened in the MRSA strains.  However, as with the previous two experiments, the presence of FBS 
again may also be a factor in the detection of fluorescence from LGX, this observation clearly requires further 
investigation.  
Additionally, the swabbing experiment was repeated, and 20 µL of each bacterial ratio (for MRSA and MSSA) 
was plated onto nutrient agar, mannitol salt agar, MRSA agar and MacConkey agar, to confirm the ratios of 
bacteria were correct and also if this method of determining a “real life” situation in the absence of culturing 
bacteria together would make a viable method for testing the protocol. Bacterial cell counts for each 
sample showed an appropriate level of bacterial species in each co-culture set based upon the defining 
parameters of said culture grouping confirming that this method does not affect cell viability of one bacteria 
over any other. 
 
The value of LGX in the detection of MRSA/MSSA without the need for culturing of the bacteria has been 
reported in the context of its use for analysing swabs from patients. In this paper, the authors report strategies for 
scale-up and show a significant increase in the achievable yield. For the first time reformation of a benzylic 
lactone after hydrogenolysis is reported for a rhodamine fluorophore and the synthetic organic significance is 
that the tripeptide substrate is unaffected by the use of DDQ, highlighting the practical value of this approach to 
an applied chemistry problem.  
The co-culturing evaluation demonstrates the potential application of LGX to surface detection of 
MRSA/MSSA in the ‘real world’ scenario. Significant fluorescence was still detectable despite the presence of 
contaminating bacterial strains (E. coli and S. epidermidis). 
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Highlights 
• Scale-up of a rapid, simple fluorescence test for MRSA/MSSA is reported for the first time. 
• MRSA/MSSA was detectable in our test despite the presence of contaminating bacterial 
strains (E. coli and S. epidermidis) 
• The co-culturing evaluation demonstrates the potential application of LGX to surface 
detection of MRSA/MSSA in the ‘real world’ scenario.  
 
